C07K

Follow

Stats

Description

PEPTIDES (peptides containing -lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D 519/02; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N 15/00)

Recent Patents

Not Available
Patent #TitleFiling DateIssue DatePatent Owner
8,815,211 Radioactive metal-labeled anti-cadherin antibody Feb 09, 11 Aug 26, 14 , FUJIFILM RI PHARMA CO., LTD.; PERSEUS PROTEOMICS INC.;
8,815,214 Fluorescent imaging agents Jan 17, 09 Aug 26, 14 , VISEN MEDICAL, INC.
8,815,240 Methods and agents for the diagnosis and treatment of hepatocellular carcinoma Mar 18, 09 Aug 26, 14 , CHINA SYNTHETIC RUBBER CORPORATION
8,815,242 Avian derived antibodies May 27, 10 Aug 26, 14 , SYNAGEVA BIOPHARMA CORP.
8,815,243 Pharmaceutical composition with antibody that binds to heat shock protein 27(HSP270) and method for promoting wound healing Aug 18, 11 Aug 26, 14 , KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES
8,815,244 Method for production of antibody using ostrich Aug 16, 11 Aug 26, 14 , JAPAN SCIENCE AND TECHNOLOGY AGENCY; OSAKA PREFECTURE UNIVERSITY PUBLIC CORPORATION;
8,815,246 Fc receptor binding proteins Sep 14, 12 Aug 26, 14 , DYAX CORP.; SYNTONIX PHARMACEUTICALS INC.;
8,815,250 Clotting factor-Fc chimeric proteins to treat hemophilia Mar 11, 13 Aug 26, 14 , BIOGEN IDEC HEMOPHILIA INC.
8,815,263 Tandem facial amphiphiles Nov 05, 12 Aug 26, 14 , WISCONSIN ALUMNI RESEARCH FOUNDATION
8,815,266 Peptide derivatives useful in the treatment, care or cleansing of the skin, mucosae, scalp or nails Jan 30, 09 Aug 26, 14 , LIPOTECH, S.A.; DIVERDRUGS, S.L; ANTONIO PUIG SA;
8,815,277 In situ forming hydrogel and biomedical use thereof Jul 01, 10 Aug 26, 14 , AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
8,815,517 Methods for identifying functionally related genes and drug targets Dec 04, 02 Aug 26, 14 , RIBONOMICS, INC.
8,815,540 Productivity augmenting protein factor, novel cell lines and uses thereof May 08, 08 Aug 26, 14 , PROBIOGEN AG
8,815,541 Method for making polypeptides Nov 25, 10 Aug 26, 14 , NOVO NORDISK A/S
8,815,542 Unnatural reactive amino acid genetic code additions Mar 06, 13 Aug 26, 14 , THE SCRIPPS RESEARCH INSTITUTE
8,815,550 Targeted perhydrolases Nov 13, 13 Aug 26, 14 , E I DU PONT DE NEMOURS AND COMPANY
8,815,562 Biosynthetic pathway for heterologous expression of a nonribosomal peptide synthetase drug and analogs Apr 15, 11 Aug 26, 14 , THE REGENYS OF THE UNIVERSITY OF MICHIGAN; ALLEGHENY-SINGER RESEARCH INSTITUTE; COLORADO STATE UNIVERSITY RESEARCH FOUNDATION;
8,815,582 light-activated ion channel protein (VChR1) Dec 18, 12 Aug 26, 14 , THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
8,815,611 Surface for label independent detection and method thereof Apr 03, 09 Aug 26, 14 , CORNING INCORPORATED
8,815,795 Methods for preventing or treating eye diseases using adiponectin Nov 26, 12 Aug 26, 14 , INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY

more results

Recent Publications

Not Available
Publication #TitleFiling DatePub DatePatent Owner
2014/0239,237 MICROBIAL NANOWIRES AND METHODS OF MAKING AND USING Feb 28, 14 Aug 28, 14 , BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY
2014/0241,984 ALPHA-SYNUCLEIN ANTIBODIES AND USES THEREOF Dec 23, 13 Aug 28, 14 , UNITED ARAB EMIRATES UNIVERSITY
2014/0241,987 ALPHA-SYNUCLEIN ANTIBODIES AND USES THEREOF Feb 28, 13 Aug 28, 14 , UNITED ARAB EMIRATES UNIVERSITY
2014/0241,988 METHODS AND COMPOSITIONS FOR TREATING ATRIAL FIBRILLATION Jan 31, 14 Aug 28, 14 , THE REGENTS OF THE UNIVERSITY OF MICHIGAN
2014/0241,993 FLUORESCENT CHLOROTOXIN CONJUGATE AND METHOD FOR INTRA-OPERATIVE VISUALIZATION OF CANCER May 08, 14 Aug 28, 14 , UNIVERSITY OF WASHINGTON; FRED HUTCHINSON CANCER RESEARCH CENTER;
2014/0241,999 PEPTIDE LINKERS FOR EFFECTIVE MULTIVALENT PEPTIDE BINDING Feb 27, 14 Aug 28, 14 , E I DU PONT DE NEMOURS AND COMPANY
2014/0242,025 MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME Feb 15, 13 Aug 28, 14 , ALTOR BIOSCIENCE CORPORATION
2014/0242,049 MUTANT CTLA4 GENE TRANSFECTED T CELL AND COMPOSITION INCLUDING SAME FOR ANTICANCER IMMUNOTHERAPY Oct 26, 12 Aug 28, 14 , NATIONAL CANCER CENTER
2014/0242,067 TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS BY INTRANASAL ADMINISTRATION OF IMMUNOGLOBULIN G Feb 25, 14 Aug 28, 14 , BAXTER HEALTHCARE SA; BAXTER INTERNATIONAL INC.;
2014/0242,068 JAML SPECIFIC BINDING AGENTS, ANTIBODIES, AND USES RELATED THERETO Aug 10, 12 Aug 28, 14 , EMORY UNIVERSITY
2014/0242,070 FRIZZLED 2 AS A TARGET FOR THERAPEUTIC ANTIBODIES IN THE TREATMENT OF CANCER Jun 15, 12 Aug 28, 14 , HARVARD UNIVERSITY PRESIDENT AND FELLOWS OF HARVARD COLLEGE
2014/0242,071 M-CSF SPECIFIC MONOCLONAL ANTIBODY AND USES THEREOF Feb 03, 14 Aug 28, 14 , XOMA TECHNOLOGY LTD.; NOVARTIS VACCINES AND DIAGNOSTICS INC.;
2014/0242,072 ANTI-ICAM-1 ANTIBODIES TO TREAT MULTIPLE-MYELOMA RELATED DISORDERS Sep 27, 12 Aug 28, 14 , BIOINVENT INTERNATIONAL AB
2014/0242,073 CARTILAGE/BONE DESTRUCTION SUPPRESSOR Aug 10, 12 Aug 28, 14 , KAGOSHIMA UNIVERSITY
2014/0242,074 MATERIALS AND METHODS FOR MODULATING ACTIVITY OF BONE MARROW DERIVED CELLS Aug 30, 12 Aug 28, 14 , UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
2014/0242,075 ANTIBODY VARIANTS AND USES THEREOF Jul 06, 12 Aug 28, 14 , GENMAB B.V.
2014/0242,076 MULTISPECIFIC MUTATED ANTIBODY FAB FRAGMENTS Jul 06, 12 Aug 28, 14 , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS); UNIVERSITE DE LAUSANNE; AZIENDA OSPEDALIERA PARA GIOVANNI XXIII;
2014/0242,077 METHODS AND COMPOSITIONS FOR MODULATING AN IMMUNE RESPONSE Jan 23, 14 Aug 28, 14 , ABBVIE INC.
2014/0242,078 METHODS AND MONITORING OF TREATMENT WITH A WNT PATHWAY INHIBITOR Feb 03, 14 Aug 28, 14 , ONCOMED PHARMACEUTICALS, INC.
2014/0242,079 BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES Feb 24, 14 Aug 28, 14 , ROCHE GLYCART AG

more results

We are sorry but your current selection exceeds the maximum number of follows () for this membership level. Upgrade to our Level for up to follows!

UPGRADE MEMBERSHIP CANCEL